The Advisors at Jubilant Therapeutics provide strategic guidance and expert insights to support the development and advancement of small molecule modulators for oncology and autoimmune diseases. Their combined expertise helps shape the company's research direction, clinical strategies, and regulatory approaches to ensure patient-focused therapeutic solutions.
View all